UVA-Developed Artificial Pancreas Effective for Children Ages 6-13, Study Finds
August 28, 2020
August 28, 2020
CHARLOTTESVILLE, Virginia, Aug. 28 -- The University of Virginia's Health System issued the following news release:
An artificial pancreas originally developed at the University of Virginia Center for Diabetes Technology safely and effectively manages blood sugar levels in children ages 6 to 13 with type 1 diabetes, a national clinical trial has found. Data from this and other studies has prompted the U.S. Food and Drug Administration to approve the device for use by children a . . .
An artificial pancreas originally developed at the University of Virginia Center for Diabetes Technology safely and effectively manages blood sugar levels in children ages 6 to 13 with type 1 diabetes, a national clinical trial has found. Data from this and other studies has prompted the U.S. Food and Drug Administration to approve the device for use by children a . . .